Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.

Sarcoma Clinical Trials

Narrow List by Age:

(Refer to Clinical Summary for age requirements)

Sarcoma

Protocol Alliance A091902
Cancer Type: ANGIOSARCOMA

A MULTICENTER PHASE II TRIAL OF PACLITAXEL WITH AND WITHOUT NIVOLUMAB IN TAXANE NAÏVE, AND NIVOLUMAB AND CABOZANTINIB IN TAXANE PRETREATED SUBJECTS WITH ANGIOSARCOMA

Please check out the rare protocol list to locate other studies within this disease site.

Protocol COG ARST1431
Cancer Type: IR Rhabdomyosarcoma
Fast Facts

A Randomized Phase III Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)

Feasibility Phase: Patients must be < 21 Years of Age at the Time of Enrollment.
Efficacy Phase: Patients must be ≤ 40 Years of Age at the Time of Enrollment.

Protocol COG ALTE16C1
Cancer Type: Sarcoma
Fast Facts

Effects of Modern Chemotherapy Regimens on  spermatogenesis and Steroidogenesis in Adolescent and Young Adult (AYA) Survivors of Osteosarcoma

Patients must be ≥ 18 and ≤ 50 Years of Age at the Time of Enrollment

Please check out the rare protocol list to locate other studies within this disease site.

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.